Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.39 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.39 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5323263 | 1.00 | LMNA (0.41) | LMNASMN1; SMN2HPGDALDH1A1HSD17B10 | |
| SCHEMBL5323369 | 0.85 | HPGD (0.49) | LMNASMN1; SMN2HPGDALDH1A1HSD17B10 | |
| SCHEMBL5323373 | 0.85 | HPGD (0.49) | LMNASMN1; SMN2HPGDALDH1A1HSD17B10 | |
| SCHEMBL28795075 | 0.84 | ALDH1A1 (0.42) | LMNASMN1; SMN2HPGDALDH1A1HSD17B10 | |
| SCHEMBL1984383 | 0.84 | ALDH1A1 (0.42) | LMNASMN1; SMN2HPGDALDH1A1HSD17B10 | |
| SCHEMBL5319450 | 0.79 | CA12 (0.46) | LMNAHPGDALDH1A1HSD17B10KDM4E | |
| SCHEMBL5319455 | 0.79 | CA12 (0.46) | LMNAHPGDALDH1A1HSD17B10KDM4E | |
| SCHEMBL9796772 | 0.77 | ALDH1A1 (0.40) | LMNASMN1; SMN2ALDH1A1CA1CA2 | |
| SCHEMBL2159580 | 0.76 | MEN1 (0.39) | LMNAHPGDALDH1A1HSD17B10CA1 | |
| SCHEMBL9504877 | 0.76 | MEN1 (0.39) | LMNAHPGDALDH1A1HSD17B10CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11904581-B2 | Bifunctional film | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2024-02-20 | — | — | US | claimed |
| US-20220388293-A1 | BIFUNCTIONAL FILM | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2022-12-08 | — | — | US | claimed |
| US-11458715-B2 | Bifunctional film and method for preparing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2022-10-04 | — | — | US | claimed |
| US-20200247101-A1 | BIFUNCTIONAL FILM AND METHOD FOR PREPARING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2020-08-06 | — | — | US | claimed |
| US-8501398-B2 | Luminescence assay using macrocyclic lanthanide (III) complexes | UNIVERSITY OF DURHAM (GB) | 2013-08-06 | — | — | US | claimed |
| US-7927620-B2 | Medical devices having antifouling character | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-04-19 | — | — | US | claimed |
| US-20100298769-A1 | IMPLANTABLE MEDICAL DEVICES FOR THERAPEUTIC AGENT DELIVERY | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2010-11-25 | — | — | US | claimed |
| WO-2010135418-A2 | IMPLANTABLE MEDICAL DEVICES FOR THERAPEUTIC AGENT DELIVERY | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2010-11-25 | — | — | WO | claimed |
| JP-2010527270-A | — | — | 2010-08-12 | — | — | JP | claimed |
| EP-2170928-A1 | ANTIBIOTIC PEPTIDES | AMP-Therapeutics GmbH & Co. KG (DE) | 2010-04-07 | — | — | EP | claimed |
| US-20100055665-A1 | LUMINESCENCE ASSAY USING MACROCYCLIC LANTHANIDE (III) COMPLEXES | UNIVERSITY OF DURHAM (GB) | 2010-03-04 | — | — | US | claimed |
| EP-2155276-A2 | MEDICAL DEVICES HAVING ANTIFOULING CHARACTER | Boston Scientific Scimed, Inc. (US) | 2010-02-24 | — | — | EP | claimed |
| EP-2041571-A1 | LUMINEESCENCE ASSAY USING MACROCYCLIC LANTHANIDE ( III ) COMPLEXES | UNIVERSITY OF DURHAM (GB) | 2009-04-01 | — | — | EP | claimed |
| WO-2009013262-A1 | ANTIBIOTIC PEPTIDES | UNIVERSITÄT LEIPZIG (DE) | 2009-01-29 | — | — | WO | claimed |
| WO-2008144392-A2 | MEDICAL DEVICES HAVING ANTIFOULING CHARACTER | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-11-27 | — | — | WO | claimed |
| US-20080286326-A1 | Medical devices having antifouling character | BOSTON SCIENTIFIC SCIMED, INC. | 2008-11-20 | — | — | US | claimed |
| WO-2008007089-A1 | LUMINEESCENCE ASSAY USING MACROCYCLIC LANTHANIDE ( III ) COMPLEXES | UNIVERSITY OF DURHAM (GB) | 2008-01-17 | — | — | WO | claimed |
| US-20070208141-A1 | MODIFIED ACRYLIC BLOCK COPOLYMERS FOR HYDROGELS AND PRESSURE SENSITIVE WET ADHESIVES | NATIONAL SCIENCE FOUNDATION | 2007-09-06 | — | — | US | claimed |
| US-4122179-A | VASODILATORS | Mora, Enrico Corvi (IT) | 1978-10-24 | — | — | US | claimed |
| WO-2024191431-A1 | ENGINEERED SELF-HEALING HYDRAULIC-CEMENT CONCRETE BY BIOMIMICRY | LIU FEIPENG (US) | 2024-09-19 | — | — | WO | disclosed |
| US-11904581-B2 | Bifunctional film | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2024-02-20 | — | — | US | disclosed |
| US-20230235216-A1 | ENGINEERED SELF-HEALING HYDRAULIC-CEMENT CONCRETE BY BIOMIMICRY | LIU FEIPENG (US) | 2023-07-27 | — | — | US | disclosed |
| CN-108619016-B | Whitening and wrinkle-improving application of aquilaria sinensis | 韩国生命工学研究院 | 2023-03-31 | — | — | CN | disclosed |
| US-20220388293-A1 | BIFUNCTIONAL FILM | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2022-12-08 | — | — | US | disclosed |
| US-11458715-B2 | Bifunctional film and method for preparing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2022-10-04 | — | — | US | disclosed |
| CN-115109795-A | Recombinant human III-type collagen injection and application thereof in skin collagen regeneration | 浙江双糖生物科技有限公司 | 2022-09-27 | — | — | CN | disclosed |
| WO-2022197778-A1 | CATECHOL CONTAINING POLYMER EMULSIONS AND METHODS OF PREPARATION THEREOF | THE UNIVERSITY OF AKRON (US) | 2022-09-22 | — | — | WO | disclosed |
| US-20200247101-A1 | BIFUNCTIONAL FILM AND METHOD FOR PREPARING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2020-08-06 | — | — | US | disclosed |
| WO-2019113710-A9 | BENZYLISOQUINOLINE UPTAKE PERMEASES AND METHODS OF USING | Willow Biosciences Inc. (CA) | 2020-02-20 | — | — | WO | disclosed |
| WO-2019113710-A1 | BENZYLISOQUINOLINE UPTAKE PERMEASES AND METHODS OF USING | SERTURNER CORP. (CA) | 2019-06-20 | — | — | WO | disclosed |
| CN-109512710-A | Cosmetic composition and method | 玫琳凯有限公司 | 2019-03-26 | — | — | CN | disclosed |
| WO-2019005829-A1 | METHODS AND COMPOSITIONS RELATING TO STEROID HORMONE RECEPTOR-DEPENDENT CANCERS | WAYNE STATE UNIVERSITY (US) | 2019-01-03 | — | — | WO | disclosed |
| CN-108567594-A | Cosmetic composition and method | 玫琳凯有限公司 | 2018-09-25 | — | — | CN | disclosed |
| WO-2018011230-A1 | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AGONISTS, METHOD OF PREPARATION AND USES THEREOF | UNIVERSITE D'AIX-MARSEILLE (FR) | 2018-01-18 | — | — | WO | disclosed |
| US-20170224598-A1 | COMPOSITION FOR COSMETIC USE SUITABLE TO PRODUCE A PIGMENTATION EFFECT ON HAIR | GIULIANI SPA (IT) | 2017-08-10 | — | — | US | disclosed |
| EP-2956117-B1 | COMPOSITION FOR COSMETIC USE SUITABLE TO PRODUCE A PIGMENTATION EFFECT ON HAIR | GIULIANI SPA (IT) | 2017-07-19 | — | — | EP | disclosed |
| US-9555217-B2 | Catheter | TERUMO KABUSHIKI KAISHA (JP) | 2017-01-31 | — | — | US | disclosed |
| US-9539191-B2 | Composition for cosmetic use suitable to produce a pigmentation effect on hair | GIULIANI S.P.A. (IT) | 2017-01-10 | — | — | US | disclosed |
| US-20160220621-A1 | COMPOSITION FOR TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS, METHOD AND USE COMPRISING ELECTROMAGNETICALLY IRRADIATED YEAST | MILMED AB (SE) | 2016-08-04 | — | — | US | disclosed |
| EP-2810680-B1 | CATHETER | TERUMO CORP (JP) | 2016-06-22 | — | — | EP | disclosed |
| CN-105687358-A | Medicine for treating vitiligo | 王银法 | 2016-06-22 | — | — | CN | disclosed |
| CN-105535076-A | Medicine prepared from angelica and tribulus terrestris and used for treating leucoderma as well as preparation method and application thereof | AN LIFENG | 2016-05-04 | — | — | CN | disclosed |
| US-9320768-B2 | Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast | MILMED AB (SE) | 2016-04-26 | — | — | US | disclosed |
| CN-105434693-A | Pharmaceutical composition for treating leucoderma | JINAN XINGYI MED TECH CO LTD | 2016-03-30 | — | — | CN | disclosed |
| CN-105287767-A | Medicine composition for treating leucoderma and preparation method thereof | JINAN XINGYI MED TECH CO LTD | 2016-02-03 | — | — | CN | disclosed |
| US-20150366770-A1 | COMPOSITION FOR COSMETIC USE SUITABLE TO PRODUCE A PIGMENTATION EFFECT ON HAIR | GIULIANI S.P.A. (IT) | 2015-12-24 | — | — | US | disclosed |
| EP-2956117-A1 | COMPOSITION FOR COSMETIC USE SUITABLE TO PRODUCE A PIGMENTATION EFFECT ON HAIR | Giuliani S.p.A. (IT) | 2015-12-23 | — | — | EP | disclosed |
| CN-105120659-A | Compositions with a rheological modifier to reduce dissolution variability | DURECT CORP | 2015-12-02 | — | — | CN | disclosed |
| CN-104324367-A | Novel application of fish scale extract in preparation of medicine for treating and/or preventing leukoderma | HUAHONG PHARMACEUTICAL CO LTD GUANGXI ZHUANG AUTONOMOUS REGION | 2015-02-04 | — | — | CN | disclosed |
| CN-104324054-A | Novel application of I-type collagen in preparation of medicine for treating and/or preventing leukoderma | HUAHONG PHARMACEUTICAL CO LTD GUANGXI ZHUANG AUTONOMOUS REGION | 2015-02-04 | — | — | CN | disclosed |
| EP-1814976-B1 | PEPTIDOMIMETIC POLYMERS FOR ANTIFOULING SURFACES | UNIV NORTHWESTERN (US) | 2015-01-07 | — | — | EP | disclosed |
| EP-2810680-A1 | CATHETER | Terumo Kabushiki Kaisha (JP) | 2014-12-10 | — | — | EP | disclosed |
| CN-104189500-A | Medicine composition for treating leucoderma, and preparation method of medicine composition | LI WANQING | 2014-12-10 | — | — | CN | disclosed |
| WO-2014125452-A1 | COMPOSITION FOR COSMETIC USE SUITABLE TO PRODUCE A PIGMENTATION EFFECT ON HAIR | GIULIANI S.P.A. (IT) | 2014-08-21 | — | — | WO | disclosed |
| EP-2470213-B1 | COMPOSITION FOR TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS, METHOD AND USE COMPRISING ELECTROMAGNETICALLY IRRADIATED YEAST | MILMED AB (SE) | 2013-10-16 | — | — | EP | disclosed |
| US-20130197454-A1 | CATHETER | TERUMO KABUSHIKI KAISHA (JP) | 2013-08-01 | — | — | US | disclosed |
| EP-2607446-A1 | Method for consolidating and/or sealing a void in a subsurface formation | Shell Internationale Research Maatschappij B.V. (NL) | 2013-06-26 | — | — | EP | disclosed |
| US-20120190095-A1 | Composition For Treatment of Neurodegenerative Diseases or Disorders, Method and Use Comprising Electromagnetically Irradiated Yeast | MB MILMED AB (SE) | 2012-07-26 | — | — | US | disclosed |
| EP-2470213-A1 | Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast | MB Milmed AB (SE) | 2012-07-04 | — | — | EP | disclosed |
| WO-2010033847-A1 | NGAL-BINDING SIDEROPHORES AND USE THEREOF TO TREAT IRON DEFICIENCY AND IRON OVERLOAD | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2010-03-25 | — | — | WO | disclosed |
| EP-2155276-A2 | MEDICAL DEVICES HAVING ANTIFOULING CHARACTER | Boston Scientific Scimed, Inc. (US) | 2010-02-24 | — | — | EP | disclosed |
| US-7618937-B2 | Peptidomimetic polymers for antifouling surfaces | NORTHWESTERN UNIVERSITY (US) | 2009-11-17 | — | — | US | disclosed |
| WO-2009077387-A1 | 2-FLUORO-4-[(3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL)AMINO]BENZOATE DERIVATIVES; COMPOSITIONS CONTAINING SAME; COSMETIC USES | L'OREAL (FR) | 2009-06-25 | — | — | WO | disclosed |
| US-7507719-B2 | Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment | INSTITUT EUROPEAN DE BIOLOGIE CELLULAIRE (FR) | 2009-03-24 | — | — | US | disclosed |
| EP-2026753-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | Mary Kay, Inc. (US) | 2009-02-25 | — | — | EP | disclosed |
| US-20090035241-A1 | Colouring composition for the skin comprising a self-tanning agent and a dye obtained by reacting an amine with dehydroascorbic acid or a monomeric polymeric or isomeric derivative thereof | L'OREAL S.A. (FR) | 2009-02-05 | — | — | US | disclosed |
| WO-2008144392-A2 | MEDICAL DEVICES HAVING ANTIFOULING CHARACTER | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2008-11-27 | — | — | WO | disclosed |
| US-20080286326-A1 | Medical devices having antifouling character | BOSTON SCIENTIFIC SCIMED, INC. | 2008-11-20 | — | — | US | disclosed |
| EP-1953235-A2 | New genes related to a process for the production of fine chemicals | Metanomics GmbH (DE) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007137128-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | MARY KAY INC. (US) | 2007-11-29 | — | — | WO | disclosed |
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
| WO-2007113385-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | KARYON-CTT LTD (FI) | 2007-10-11 | — | — | WO | disclosed |
| EP-1814976-A2 | PEPTIDOMIMETIC POLYMERS FOR ANTIFOULING SURFACES | Northwestern University (US) | 2007-08-08 | — | — | EP | disclosed |
| US-20070004633-A1 | Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment | INSTITUT EUROPEEN DE BIOLOGIE CELLULAIRE (FR) | 2007-01-04 | — | — | US | disclosed |
| US-20060241281-A1 | Peptidomimetic polymers for antifouling surfaces | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-10-26 | — | — | US | disclosed |
| US-7122719-B2 | Method of imparting disease resistance to plants by reducing polyphenol oxidase activities | MONSANTO TECHNOLOGY LLC (US) | 2006-10-17 | — | — | US | disclosed |
| WO-2006055531-A2 | PEPTIDOMIMETIC POLYMERS FOR ANTIFOULING SURFACES | NORTHWESTERN UNIVERSITY (US) | 2006-05-26 | — | — | WO | disclosed |
| EP-1643968-A1 | IMPLANTABLE ELASTOMERIC DEPOT COMPOSITIONS, USES THEREOF AND METHOD OF MANUFACTURING | ALZA Corporation (US) | 2006-04-12 | — | — | EP | disclosed |
| US-20050175556-A1 | Skin Darkening (Sunless Tanning) Compositions Based on Enhancement of Melanin Synthesis by Tyrosinase Promoters | BIODERM RESEARCH (US) | 2005-08-11 | — | — | US | disclosed |
| US-20050101484-A1 | Method of imparting disease resistance to plants by reducing polyphenol oxidase activities | MONSANTO TECHNOLOGY LLC | 2005-05-12 | — | — | US | disclosed |
| WO-2004108111-A1 | IMPLANTABLE ELASTOMERIC DEPOT COMPOSITIONS, USES THEREOF AND METHOD OF MANUFACTURING | ALZA CORPORATION (US) | 2004-12-16 | — | — | WO | disclosed |
| US-20040161391-A1 | Ascorbic acid compounds as bleaching agents | L'OREAL (FR) | 2004-08-19 | — | — | US | disclosed |
| EP-1356065-A2 | METHOD OF IMPARTING DISEASE RESISTANCE TO PLANTS BY REDUCING POLYPHENOL OXIDASE ACTIVITY | Monsanto Technology LLC (US) | 2003-10-29 | — | — | EP | disclosed |
| US-6551581-B1 | Methylthioadenosine to increase pigmentation and a cosmetic vehicle for skin, scalp, or hair; \"self-tanning\" or sunless tanning; methylthioadenosine acts as an accelerator of the enzymes involved in biosynthesis of melanins | AVON PRODUCTS, INC. | 2003-04-22 | — | — | US | disclosed |
| EP-0937156-B1 | PREPARATION OF D-AMINO ACIDS BY DIRECT FERMENTATIVE MEANS | PCBU SERVICES INC (US) | 2003-03-19 | — | — | EP | disclosed |
| WO-2002061101-A2 | METHOD OF IMPARTING DISEASE RESISTANCE TO PLANTS BY REDUCING POLYPHENOL OXIDASE ACTIVITY | MONSANTO TECHNOLOGY LLC (US) | 2002-08-08 | — | — | WO | disclosed |
| US-6380263-B1 | ADMINISTERING TO HUMAN EFFECTIVE TYROSINASE ACTIVITY-STIMULATING AMOUNT OF AT LEAST ONE 6-SUBSTITUTED PYRIMIDINE 3-OXIDE COMPOUND FOR PROMOTING PIGMENTATION OF THE SKIN AND/OR HAIR | SOCIETE L'OREAL (FR) | 2002-04-30 | — | — | US | disclosed |
| US-6371993-B1 | HAIR DYES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-04-16 | — | — | US | disclosed |
| US-6203579-B1 | MIXTURE OF ISATIN DERIVATIVE AND AMINO COMPOUND | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-03-20 | — | — | US | disclosed |
| US-6042872-A | HEAT-COAGULATED POTATO PROTEIN IS FIRST SEPARATED FROM THE POTATO JUICE AND THEN IS TREATED WITH AQUEOUS INORGANIC ACID SOLUTION(S) TO REDUCE GLYCOALKALOIDS, RECOVERING TREATED PRODUCT | COOPERATIEVE VERKOOP-EN PRODUCTIEVERENIGING VAN AARDAPPELMEEL EN DERIVATEN AVEBE B.A. (NL) | 2000-03-28 | — | — | US | disclosed |
| EP-0839003-B1 | PURIFIED HEAT-COAGULATED POTATO PROTEIN FOR USE IN ANIMAL FEED | AVEBE COOP VERKOOP PROD (NL) | 1999-12-29 | — | — | EP | disclosed |
| US-5919318-A | NITROBENZENESULFONIC ACID | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1999-07-06 | — | — | US | disclosed |
| EP-0839003-A1 | PURIFIED HEAT-COAGULATED POTATO PROTEIN FOR USE IN ANIMAL FEED | Coöperatieve Verkoop- en Productievereniging van Aardappelmeel en Derivaten 'AVEBE' B.A. (NL) | 1998-05-06 | — | — | EP | disclosed |
| US-5665375-A | REDUCING FAT AND CHOLESTEROL CONTENT BY ADMINISTERING L-DOPA (DIHYDROXYPHENYL ALANINE) TO POULTRY | BOARD OF SUPERVISORS OF LOUISIANA UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 1997-09-09 | — | — | US | disclosed |
| WO-1997003571-A1 | PURIFIED HEAT-COAGULATED POTATO PROTEIN FOR USE IN ANIMAL FEED | COÖPERATIEVE VERKOOP- EN PRODUCTIEVERENIGING VAN AARDAPPELMEEL EN DERIVATEN AVEBE B.A. (NL) | 1997-02-06 | — | — | WO | disclosed |
| US-5417682-A | Device for administering active agent to biological environment | ALZA CORPORATION (US) | 1995-05-23 | — | — | US | disclosed |
| WO-1994017781-A1 | ENDONUCLEASE-ENHANCED TANNING | TRUSTEES OF BOSTON UNIVERSITY (US) | 1994-08-18 | — | — | WO | disclosed |
| EP-0580409-A2 | Cosmetic composition containing DOPA derivatives | UNILEVER PLC (GB) | 1994-01-26 | — | — | EP | disclosed |
| US-4868106-A | IMMUNOASSAY, POROUS REACTION LAYER | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1989-09-19 | — | — | US | disclosed |
| EP-0083612-A1 | NEW DERIVATIVES OF DIPEPTIDES, METHOD FOR THE PREPARATION THEREOF AND UTILIZATION THEREOF AS DRUGS | FLORK, Michel (FR) | 1983-07-20 | — | — | EP | disclosed |
| EP-0028251-B1 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER | ETHYL CORPORATION (US) | 1983-03-16 | — | — | EP | disclosed |
| WO-1983000146-A1 | NEW DERIVATIVES OF DIPEPTIDES, METHOD FOR THE PREPARATION THEREOF AND UTILIZATION THEREOF AS DRUGS | FLORK, MICHEL | 1983-01-20 | — | — | WO | disclosed |
| US-4287102-A | CONTAINING A WATER SOLUBLE SALT OF OLEFIN SULFONIC ACID, AND A TERTIARY AMINE OXIDE | THE LION FAT & OIL CO., LTD. (JP) | 1981-09-01 | — | — | US | disclosed |
| US-4175084-A | AND AN N-ACYL ASPARTIC ACID CARRIER, FOR PSYCHOLOGICAL DISORDERS, LEARNING ENHANCEMENT AND SLEEP INDUCTION | SENTRALINSTITUTT FOR INDUSTRIELL FORSKNING (NO) | 1979-11-20 | — | — | US | disclosed |
| US-4067890-A | Oxidative coupling of alkylphenols, alkoxyphenols and naphthols catalyzed by metal complexes of amino carboxylic and amino sulfonic acids | ICI AMERICA INC. (US) | 1978-01-10 | — | — | US | disclosed |
| US-4067890-A | Oxidative coupling of alkylphenols, alkoxyphenols and naphthols catalyzed by metal complexes of amino carboxylic and amino sulfonic acids | ICI AMERICA INC. (US) | 1978-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035241-A1 | Colouring composition for the skin comprising a self-tanning agent and a dye obtained by reacting an amine with dehydroascorbic acid or a monomeric polymeric or isomeric derivative thereof | ADH7, TYR, ADH1B | LMNA 4105/4885SMN1; SMN2 4639/4885HPGD 58/4885 |
| US-20040161391-A1 | Ascorbic acid compounds as bleaching agents | CAT, GPX4, TYR | LMNA 1362/4885SMN1; SMN2 3841/4885HPGD 1370/4885 |
| US-20060241281-A1 | Peptidomimetic polymers for antifouling surfaces | MSN, LNPEP, PNMT | LMNA 4165/4885SMN1; SMN2 3369/4885HPGD 3930/4885 |
| US-20100298769-A1 | IMPLANTABLE MEDICAL DEVICES FOR THERAPEUTIC AGENT DELIVERY | PGF, BMP6, IL6 | LMNA 4045/4885SMN1; SMN2 3671/4885HPGD 189/4885 |
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | LMNA 3163/4885SMN1; SMN2 3998/4885HPGD 1508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.